Chromatin Revenue and Competitors
Estimated Revenue & Valuation
- Chromatin's estimated annual revenue is currently $8.1M per year. 0
- Chromatin's total funding is $122.3M.
Employee Data
- 00
Chromatin's People
Name | Title | Email/Phone |
---|
Chromatin Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.8M | 18 | -14% | N/A | N/A |
#2 | $0.8M | 5 | 0% | N/A | N/A |
#3 | $2M | 13 | 0% | N/A | N/A |
#4 | $707.3M | 2852 | 14% | $1.1B | N/A |
#5 | $1.7M | 11 | 0% | N/A | N/A |
#6 | $32.6M | 210 | 6% | N/A | N/A |
#7 | $2.6M | 17 | 6% | N/A | N/A |
#8 | $1.1M | 7 | -30% | N/A | N/A |
#9 | $1.4M | 9 | -10% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Chromatin?
Chromatin, Inc. is headquartered in Chicago, IL and was founded in 2000, based on technology developed in the laboratory of Dr. Daphne Preuss and her colleagues at the University of Chicago. Chromatin's mini-chromosome technology is designed to significantly accelerate the pace of crop improvement, enabling the rapid delivery of large numbers of genes. The company's suite of intellectual property enables the development of crops with improved genetics to enhance nutritional value, and food safety, and can accelerate the discovery and development of affordable pharmaceuticals and production of industrial and consumer products.
keywords:N/A$122.3M
Total Funding
N/A
Number of Employees
$8.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Chromatin News
Snf2-like chromatin remodellers couple the energy of ATP binding and hydrolysis to reposition and recompose the nucleosome, and have vital...
To this end, the extent of chromatin accessibility and gene expression in peripheral blood mononuclear cells (PBMCs), comprising several...
Seed points may spread the chromatin hyperacetylation in the nucleus of the nerve cells of the immature brain, resulting in psychiatric...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $266.3M | 0 | N/A | $497M |
#2 | $13M | 0 | N/A | $13.5M |
#3 | $64.4M | 0 | N/A | $80.3M |
#4 | $7M | 0 | N/A | $11.4M |
#5 | $6.2M | 0 | N/A | $18.3M |